Renata J. Walewska

Bournemouth, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Individualised but Specific Exercise Training Improves Physiologic Reserve and Reduces Frailty in Older Adults with Chronic Lymphocytic Leukaemia: A 12-Week Pragmatic Randomised Controlled Trial.

Individualised but Specific Exercise Training Improves Physiologic Reserve and Reduces Frailty in Older Adults with Chronic Lymphocytic Leukaemia: A 12-Week Pragmatic Randomised Controlled Trial.

Journal: medRxiv : the preprint server for health sciences

Published: August 20, 2026

Trends and socio-economic disparities in chronic lymphocytic leukaemia 2014-2022: An England-wide cohort study from the UNCOVER group.

Trends and socio-economic disparities in chronic lymphocytic leukaemia 2014-2022: An England-wide cohort study from the UNCOVER group.

Journal: British journal of haematology

Published: April 02, 2026

Acalabrutinib monotherapy as a first-line treatment for CLL: 3 years follow-up of the real-world EPIC study.

Acalabrutinib monotherapy as a first-line treatment for CLL: 3 years follow-up of the real-world EPIC study.

Journal: Blood advances

Published: February 04, 2026

Acalabrutinib monotherapy as a first-line treatment for CLL: 3-year follow-up of the real-world EPIC study.

Acalabrutinib monotherapy as a first-line treatment for CLL: 3-year follow-up of the real-world EPIC study.

Journal: Blood advances

Published: February 04, 2026

Integrated multi-omic profiling reveals two distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

Integrated multi-omic profiling reveals two distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

Journal: Blood advances

Published: December 09, 2025

Integrated multiomic profiling reveals 2 distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

Integrated multiomic profiling reveals 2 distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

Journal: Blood advances

Published: December 09, 2025

Primary Cutaneous Diffuse Large B-Cell Lymphoma With Initial Atypical Clinical Presentation as Annular and Arcuate Plaques, Histologically Mimicking Interstitial Granulomatous Dermatitis.

Primary Cutaneous Diffuse Large B-Cell Lymphoma With Initial Atypical Clinical Presentation as Annular and Arcuate Plaques, Histologically Mimicking Interstitial Granulomatous Dermatitis.

Journal: The American Journal of dermatopathology

Published: October 23, 2025

High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights.

High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights.

Journal: Leukemia

Published: October 13, 2025

Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.

Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.

Journal: The New England journal of medicine

Published: June 16, 2025

Physical Activity, Symptoms, Quality of Life and Exercise Program Preferences in People With Chronic Lymphocytic Leukaemia.

Physical Activity, Symptoms, Quality of Life and Exercise Program Preferences in People With Chronic Lymphocytic Leukaemia.

Journal: EJHaem

Published: June 16, 2025

2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemia.

2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemia.

Journal: British journal of haematology

Published: May 05, 2025

Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.

Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.

Journal: Leukemia

Published: January 03, 2025

Showing 1-12 of 55

Last Updated: 09/26/2026